Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-003913-15Phase 4Completed
Phase 4, open-label, single-arm trial of oxcarbazepine in temporal lobe epilepsy (TLE), sponsored by Medical University of Innsbruck. Primary endpoint: Total degradation markers of endogenous cortisol. Started Oct 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-003913-15.